You are here

  • Home
  • Archive
  • Volume 4, Issue 1
  • Dipeptidyl peptidase-4 inhibition by Saxagliptin prevents inflammation and renal injury by targeting the Nlrp3/ASC inflammasome

Article metrics

Article menu

Download PDFPDF

XML
Pharmacology and Therapeutics
Dipeptidyl peptidase-4 inhibition by Saxagliptin prevents inflammation and renal injury by targeting the Nlrp3/ASC inflammasome

 

Online download statistics by month:

Online download statistics by month: August 2016 to April 2023

AbstractFullPdf
Aug 2016322369153
Sep 201618016794
Oct 2016177124113
Nov 20167627183
Dec 20161287043
Jan 2017221610
Feb 20171817
Mar 201717014
Apr 2017112426
May 201707428
Jun 2017246137
Jul 2017404032
Aug 2017464438
Sep 2017343323
Oct 2017444321
Nov 2017505034
Dec 2017535320
Jan 2018474722
Feb 2018594924
Mar 2018828215
Apr 201812312331
May 2018616432
Jun 2018454617
Jul 2018636324
Aug 2018404026
Sep 2018484714
Oct 201831299
Nov 201810210235
Dec 201817217232
Jan 201913613522
Feb 201914914923
Mar 2019656513
Apr 2019252512
May 2019202017
Jun 2019282615
Jul 2019272726
Aug 2019121211
Sep 2019212119
Oct 2019242415
Nov 2019151520
Dec 2019434313
Jan 2020222120
Feb 202018178
Mar 2020272721
Apr 2020191929
May 2020202010
Jun 2020282620
Jul 2020292517
Aug 202017179
Sep 2020282218
Oct 2020454110
Nov 2020432513
Dec 2020251813
Jan 202123219
Feb 2021262013
Mar 2021362613
Apr 2021201810
May 2021191916
Jun 2021232315
Jul 2021141413
Aug 2021282727
Sep 2021353525
Oct 2021312727
Nov 2021292517
Dec 202131275
Jan 2022222110
Feb 202219619210
Mar 2022585912
Apr 202295968
May 2022292618
Jun 202222206
Jul 202214113
Aug 2022171510
Sep 20222622114
Oct 2022252413
Nov 2022252621
Dec 202245369
Jan 2023333111
Feb 2023615132
Mar 2023444321
Apr 2023101012
Total399542861961